Purple Biotech (PPBT) News Today $3.17 -0.08 (-2.46%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$3.14 -0.02 (-0.79%) As of 02/21/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Purple Biotech advances NT219 into Phase 2 head, neck cancer trialFebruary 18, 2025 | markets.businessinsider.comPurple Biotech Advances NT219 into Phase 2 Head and Neck Cancer TrialFebruary 18, 2025 | globenewswire.comPurple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody PlatformFebruary 4, 2025 | markets.businessinsider.comPurple Biotech announces research collaboration with Icahn School of MedicineFebruary 4, 2025 | markets.businessinsider.comPurple Biotech Ltd. American Depositary Shares (PPBT)December 5, 2024 | nasdaq.comPurple Biotech Ltd. Closes $2.8 Million Registered Direct Offering of American Depositary SharesDecember 5, 2024 | quiverquant.comPurple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary SharesDecember 5, 2024 | globenewswire.comPurple Biotech Secures $2.8 Million Through ADS OfferingDecember 4, 2024 | markets.businessinsider.comPurple Biotech to sell 472,668 ADSs at $6.00 in registered direct offeringDecember 4, 2024 | markets.businessinsider.comWhy Purple Biotech (PPBT) Stock Is Getting HammeredDecember 4, 2024 | benzinga.comPurple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary SharesDecember 3, 2024 | globenewswire.comPurple Biotech reports final results from randomized Phase 2 study of CM24December 2, 2024 | markets.businessinsider.comPurple Biotech Shares Jump on Positive Phase 2 Cancer Drug Study ResultsDecember 2, 2024 | marketwatch.comPurple Biotech Reports Positive Final Data From Phase 2 Study Of CM24 In Pancreatic Cancer; Stock UpDecember 2, 2024 | markets.businessinsider.comPurple Biotech Stock Hits Nearly 2-Month High On Cancer Drug Trial Success: Retail ThrilledDecember 2, 2024 | msn.comPurple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic CancerDecember 2, 2024 | markets.businessinsider.comPurple Biotech Ltd.: Purple Biotech Reports Third Quarter 2024 Financial ResultsNovember 16, 2024 | finanznachrichten.dePurple Biotech reports Q3 EPS (39c) vs ($4.63) last yearNovember 16, 2024 | markets.businessinsider.comPromising Interim Results Propel Purple Biotech’s Buy Rating Amid Phase 2 Success and Strategic AdvancementsNovember 16, 2024 | markets.businessinsider.comPurple Biotech Ltd. Reports Progress in Phase 2 CM24 Pancreatic Cancer Trial and Biomarker Developments, Financial Results for Q3 2024November 15, 2024 | quiverquant.comPurple Biotech Reports Third Quarter 2024 Financial ResultsNovember 15, 2024 | globenewswire.comPurple Biotech Unveils Promising Biomarker for Cancer TherapyNovember 5, 2024 | finance.yahoo.comPurple Biotech identifies potential new serum biomarker for CM24November 4, 2024 | markets.businessinsider.comPurple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of DeathNovember 4, 2024 | globenewswire.comPurple Biotech (NASDAQ:PPBT) Stock, Option ChainNovember 3, 2024 | benzinga.comPurple Biotech (NASDAQ:PPBT) Stock, Short Interest ReportNovember 2, 2024 | benzinga.comPurple Biotech Advances with CAPTN-3 Cancer PlatformOctober 25, 2024 | markets.businessinsider.comPurple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsOctober 25, 2024 | globenewswire.comPurple Biotech Unveils CAPTN-3 Cancer TherapyOctober 11, 2024 | finance.yahoo.comPurple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsOctober 10, 2024 | globenewswire.comPurple Biotech (NASDAQ:PPBT) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comQ3 2024 EPS Estimates for Purple Biotech Ltd Reduced by Analyst (NASDAQ:PPBT)Purple Biotech Ltd (NASDAQ:PPBT - Free Report) - Analysts at HC Wainwright cut their Q3 2024 EPS estimates for Purple Biotech in a research report issued on Thursday, September 19th. HC Wainwright analyst E. Bodnar now forecasts that the company will earn ($1.20) per share for the quarter, down fSeptember 23, 2024 | marketbeat.comPurple Biotech (NASDAQ:PPBT) PT Raised to $33.00 at HC WainwrightHC Wainwright upped their price target on Purple Biotech from $8.00 to $33.00 and gave the stock a "buy" rating in a research note on Friday.September 20, 2024 | marketbeat.comBuy Rating Justified by Promising CM24 Phase 2 Study for Pancreatic Cancer SurvivalSeptember 19, 2024 | markets.businessinsider.comPurple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24September 18, 2024 | globenewswire.comPurple Biotech Ltd (1YI1.MU)September 17, 2024 | uk.finance.yahoo.com1YI1.SG,0P0001D6KB,0 (1YI1.SG)September 17, 2024 | au.finance.yahoo.comPurple Biotech Ltd (1YI1.DU)September 17, 2024 | sg.finance.yahoo.comPurple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer ResearchSeptember 10, 2024 | markets.businessinsider.comPurple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment ConferenceAugust 30, 2024 | globenewswire.comPPBT Purple Biotech LtdAugust 24, 2024 | seekingalpha.comPurple Biotech Ltd.: Purple Biotech Reports Second Quarter 2024 Financial Results and Business HighlightsAugust 16, 2024 | finanznachrichten.dePurple Holds its Own on Quarterly NumbersAugust 16, 2024 | msn.comPurple Biotech Reports Second Quarter 2024 Financial Results and Business HighlightsAugust 16, 2024 | globenewswire.comPurple Biotech Ltd (PPBT.TA)August 8, 2024 | finance.yahoo.comPurple Biotech Ltd.: Purple Biotech Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price RuleJuly 25, 2024 | finanznachrichten.dePurple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price RuleJuly 25, 2024 | finance.yahoo.comPurple Biotech Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price RuleJuly 25, 2024 | globenewswire.comPurple Biotech to Host Virtual KOL Event to Discuss Positive Interim Results from Phase 2 Pancreatic Cancer Study with CM24 on July 11, 2024July 10, 2024 | globenewswire.comPurple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross ProceedsJuly 2, 2024 | globenewswire.com Get Purple Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter. Email Address PPBT Media Mentions By Week PPBT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PPBT News Sentiment▼-0.880.60▲Average Medical News Sentiment PPBT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PPBT Articles This Week▼21▲PPBT Articles Average Week Get Purple Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Synlogic News Today GeoVax Labs News Today NeuroSense Therapeutics News Today Biomerica News Today Eagle Pharmaceuticals News Today HCW Biologics News Today Cingulate News Today CervoMed News Today Phio Pharmaceuticals News Today Minerva Neurosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PPBT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
